Cargando…

Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies

Reactivation of hepatitis B virus (HBV) is a major problem in patients receiving chemotherapy for malignant diseases or immunosuppression therapies. It has been thought that a reduction in the immune responses might result in the reactivation of HBV replication from covalently closed circular DNA (c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Jun, Nakamura, Takuya, Masamune, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563158/ https://www.ncbi.nlm.nih.gov/pubmed/31109119 http://dx.doi.org/10.3390/v11050457

Ejemplares similares

Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
por: Lazarevic, Ivana, et al.
Publicado: (2019)

Envelope Proteins of Hepatitis B Virus: Molecular Biology and Involvement in Carcinogenesis
por: Inoue, Jun, et al.
Publicado: (2021)

Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation
por: Tsuruoka, Mio, et al.
Publicado: (2021)

Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
por: Elsebaey, Mohamed A., et al.
Publicado: (2022)

Prevention of Hepatitis B reactivation in the setting of immunosuppression
por: Pattullo, Venessa
Publicado: (2016)

Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021)

Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy
por: Asai, Akira, et al.
Publicado: (2022)

Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment
por: Spera, Anna Maria
Publicado: (2022)

Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
por: Yoo, Dae San, et al.
Publicado: (2020)

Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Onorato, Lorenzo, et al.
Publicado: (2021)

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2021)

The Exosome‐Associated Tetraspanin CD63 Contributes to the Efficient Assembly and Infectivity of the Hepatitis B Virus
por: Ninomiya, Masashi, et al.
Publicado: (2021)

COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report
por: Wu, Yi-Feng, et al.
Publicado: (2021)

Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID-19 (Review)
por: Baroiu, Liliana, et al.
Publicado: (2022)

Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy
por: Kawagishi, Naoki, et al.
Publicado: (2022)

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2022)

Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report
por: Caviglia, Gian Paolo, et al.
Publicado: (2021)

Acute-onset Autoimmune Hepatitis in a Patient with Selective Immunoglobulin M Deficiency
por: Sano, Akitoshi, et al.
Publicado: (2019)

Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy
por: Lee, Hae Lim, et al.
Publicado: (2017)

Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review
por: Cholongitas, Evangelos, et al.
Publicado: (2018)

Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
por: Tavakolpour, Soheil, et al.
Publicado: (2016)

Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines
por: Etienne, Samuel, et al.
Publicado: (2022)

Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy
por: Zou, Xiaofang, et al.
Publicado: (2020)

Inhibitory effect of silibinin on hepatitis B virus entry
por: Umetsu, Teruyuki, et al.
Publicado: (2018)

Patients with Coexistence of Circulating Hepatitis B Surface Antigen and Its Antibody May Have a Strong Predisposition to Virus Reactivation During Immunosuppressive Therapy: A Hypothesis
por: Chen, Yu-Lan, et al.
Publicado: (2017)

Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy
por: Lam, Lok-Ka, et al.
Publicado: (2023)

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis
por: Ciardi, Maria R, et al.
Publicado: (2018)

Role of viral infections in immunosuppressed patients
por: Salavert, M., et al.
Publicado: (2011)

Prophylactic effect of tenofovir on viral reactivation in immunocompromised pregnant women living with hepatitis B virus
por: Zhang, Le, et al.
Publicado: (2022)

Hepatitis B virus reactivation with corticosteroid therapy in patients with adrenal insufficiency
por: Hatano, Masako, et al.
Publicado: (2019)

Reactivation of Hepatitis B After Ibalizumab Therapy for Multidrug-Resistant Human Immunodeficiency Virus
por: Kaplan, Alyson, et al.
Publicado: (2021)

HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations
por: Anastasiou, Olympia E., et al.
Publicado: (2017)

Immunosuppression in Patients with Chronic Hepatitis B
por: Seetharam, Anil, et al.
Publicado: (2014)

Risk of Hepatitis B Virus Reactivation in Patients with Resolved Infection on Therapy with Corticosteroids and Conventional Synthesis Immunosuppressants for Kidney Disease: A Single-Center Analysis of 258 Patients
por: Han, Pingyang, et al.
Publicado: (2023)

Hepatitis B virus reactivation in rheumatoid arthritis
por: Wu, Ya-Li, et al.
Publicado: (2022)

The Novel Immunosuppressive Protein Kinase C Inhibitor Sotrastaurin Has No Pro-Viral Effects on the Replication Cycle of Hepatitis B or C Virus
por: von Hahn, Thomas, et al.
Publicado: (2011)

Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
por: Wang, Changtai, et al.
Publicado: (2019)

Occult Hepatitis B Reactivation after Liver Transplant: The Role of a Novel Mutation in the Surface Antigen
por: Bedi, Harjot K., et al.
Publicado: (2021)

Treatment or Prophylaxis against Hepatitis B Virus Infection in Patients with Rheumatic Disease Undergoing Immunosuppressive Therapy: An Update
por: Stasi, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r1iaj7isre08vs487mpr5rgdq5